Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Multi-centre Study in Patients With Von Willebrand Disease to Investigate the Pharmacokinetics, Efficacy and Safety of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate

NCT00387192 is registered in ClinicalTrials.gov with Bio Products Laboratory as lead sponsor.

NCT NCT00387192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00387192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Multi-centre Study in Patients With Von Willebrand Disease to Investigate the Pharmacokinetics, Efficacy and Safety of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and Von Willebrand Factor Concentrate
Lead sponsor
Bio Products Laboratory
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2006
Completion date
September 30, 2008
Enrollment
26 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

von willebrand disease